CIS Cardiologist is First to Implant MRI-Compatible Cardiac Device in Lafayette

LAFAYETTE– Dr. Marc Saad, electrophysiologist at CardiovascularDr. Marc Saad Institute of the South (CIS) and Lafayette General Medical Center (LGMC), was the first in Lafayette and the second in the state to utilize a new implantable cardioverter defibrillator (ICD) system that is FDA approved for use with magnetic resonance imaging (MRI) scans.

ICDs detect irregular heartbeats and deliver life-saving therapy to restore a patient’s normal heartbeat.  However, patients with ICDs have not previously been able to receive MRI scans because of potential high risk interactions between the MRI and the device function.  These MRI restrictions have resulted in a critical need, as more than one-third of patients with ICDs are likely to need an MRI.

Medtronic SureScan CSI Lafayette“Patients with ICDs are often older adults with other serious medical conditions that require an MRI for diagnosis,” explained Dr. Saad.  “CIS and LGH are grateful to have this game-changing technology that helps treat cardiac arrest and enables patients to access MRIs, allowing us to provide exceptional care.”

An ICD is a small implantable heart device that is placed under the skin, typically just below the collarbone on the left side of the chest.  For patients at risk of a life-threatening cardiac event, ICDs may be prescribed to continuously monitor heart rate and deliver an electrical signal to correct an abnormal heart rate, if detected. 

An MRI is an imaging test used regularly for a wide-range of diagnoses including conditions such as stroke, cancer, Alzheimer’s disease, and muscle, bone and back pain, all which are prevalent among older adults.

About the Evera MRI

The Evera MRI™ SureScan® ICD System from Medtronic has been FDA approved to allow for MRI scans on any part of the body. The system includes design enhancements from previous generation devices that allow it to safely undergo full-body MRIs, while maintaining the same longevity, proven shock reduction and physical size and shape of the original Evera ICD. The device is paired with the Sprint Quattro® Secure MRI SureScan® DF4 leads, backed by more than 10 years of proven performance with active monitoring, now tested for safe use during an MRI.  The FDA approval of the Evera MRI ICD system was based on safety and efficacy data from the randomized, controlled Evera MRI clinical trial that demonstrated that the Evera MRI ICD system is safe and effective, and that full-body MRI scans did not affect its ability to deliver life-saving therapy.  For more information or photos of the Evera MRI ICD system, please visit


Latest News

CIS Staff

Written by CIS Staff